A Fierce Mother vs. a Fatal Mutation

Amber Salzman, whose determination to find a cure for her son's rare disease led to a recently successful clinical trial using gene therapy.

(Courtesy of Salzman)


Keep ReadingKeep Reading
Amber Salzman
Amber Salzman currently serves as President and CEO of Adverum Biotechnologies (NASDAQ: ADVM) and as President of The Stop ALD Foundation.